株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

核医学の世界市場:動向分析・予測

Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027

発行 Accuray Research 商品コード 373628
出版日 ページ情報 英文 184 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.06円で換算しております。
Back to Top
核医学の世界市場:動向分析・予測 Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027
出版日: 2018年10月01日 ページ情報: 英文 184 Pages
概要

当レポートでは、世界の核医学の市場を調査し、市場の定義と概要、市場への各種影響因子および市場機会の分析、関連法規制、用途・処置区分・タイプ・安定同位体・地域/主要国など各種詳細区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 市場概要

  • 調査手法
  • 市場動向
  • 法規制上の影響因子
  • 各種用途の分析
  • エンドユーザーの分析
  • 戦略ベンチマーキング
  • 市場機会の分析

第2章 エグゼクティブサマリー

第3章 市場概要

  • 現在の動向
  • 成長推進因子
  • 成長抑制因子
  • 産業の魅力

第4章 市場分析・予測:用途別

  • 治療用途
    • 内分泌腫瘍
    • 骨転移
    • 甲状腺
    • リンパ腫
    • 神経科
    • 心臓
    • 腎臓
    • その他
  • 診断用途
    • PET
    • SPECT

第5章 市場分析・予測:処置別

  • 治療的処置
  • 診断的処置

第6章 市場分析・予測:エンドユーザー別

  • 学術研究機関
  • 各種産業
  • 医療
    • 診断センター
    • 病院

第7章 市場分析・予測:タイプ別

  • 核医学診療/放射性医薬品
    • 密封小線源治療 (ブラキセラピー) 同位体
    • ベータ放射体
    • アルファ放射体
  • 核医学診断/放射性医薬品
    • PET放射性医薬品
    • SPECT放射性医薬品

第8章 市場分析・予測:安定同位体別

  • 炭素 (C-13)
  • 窒素 (N-15)
  • 硫黄 (S-32)
  • 酸素 (O-18)
  • 重水素 (D2)
  • その他

第9章 市場分析・予測:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • スぺイン
    • 英国
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • ニュージーランド
    • その他
  • 中東
    • サウジアラビア
    • UAE
    • その他
  • ラテンアメリカ
    • アルゼンチン
    • ブラジル
    • その他
  • その他の地域
    • アフリカ
    • カリブ海諸国

第10章 企業間の動向

  • M&A
  • 合意・JV・提携・協力
  • 製品の投入・拡張
  • その他

第11章 主要企業

図表

List of Tables

  • Table 1: Global Nuclear Medicine Market By Region, Market Forecast(2015-2027)(US $MN)
  • Table 2: Global Nuclear Medicine Market By Therapeutic Products, Market Forecast(2015-2027)(US $MN)
  • Table 3: Global Nuclear Medicine Market By Brachytherapy, Market Forecast(2015-2027)(US $MN)
  • Table 4: Global Nuclear Medicine Market By Alpha Emitters, Market Forecast(2015-2027)(US $MN)
  • Table 5: Global Nuclear Medicine Market By Beta Emitters, Market Forecast(2015-2027)(US $MN)
  • Table 6: Global Nuclear Medicine Market By Diagnostic Products, Market Forecast(2015-2027)(US $MN)
  • Table 7: Global Nuclear Medicine Market By PET Radiopharmaceuticals, Market Forecast(2015-2027)(US $MN)
  • Table 8: Global Nuclear Medicine Market By SPECT Radiopharmaceuticals, Market Forecast(2015-2027)(US $MN)
  • Table 9: Global Nuclear Medicine Market By Procedures, Market Forecast(2015-2027)(US $MN)
  • Table 10: Global Nuclear Medicine Market By Central Nervous System, Market Forecast(2015-2027)(US $MN)
  • Table 11: Global Nuclear Medicine Market By Gastrointestinal, Market Forecast(2015-2027)(US $MN)
  • Table 12: Global Nuclear Medicine Market By Pulmonary, Market Forecast(2015-2027)(US $MN)
  • Table 13: Global Nuclear Medicine Market By Therapeutic, Market Forecast(2015-2027)(US $MN)
  • Table 14: Global Nuclear Medicine Market By Cardiovascular, Market Forecast(2015-2027)(US $MN)
  • Table 15: Global Nuclear Medicine Market By Endocrine, Market Forecast(2015-2027)(US $MN)
  • Table 16: Global Nuclear Medicine Market By Genito-Urinary, Market Forecast(2015-2027)(US $MN)
  • Table 17: Global Nuclear Medicine Market By PET & PET-CT, Market Forecast(2015-2027)(US $MN)
  • Table 18: Global Nuclear Medicine Market By Skeletal, Market Forecast(2015-2027)(US $MN)
  • Table 19: Global Nuclear Medicine Market By Other Procedures, Market Forecast(2015-2027)(US $MN)
  • Table 20: Global Nuclear Medicine Market By Application, Market Forecast(2015-2027)(US $MN)
  • Table 21: Global Nuclear Medicine Market By Therapeutic Application, Market Forecast(2015-2027)(US $MN)
  • Table 22: Global Nuclear Medicine Market By Lymphoma, Market Forecast(2015-2027)(US $MN)
  • Table 23: Global Nuclear Medicine Market By Thyroid, Market Forecast(2015-2027)(US $MN)
  • Table 24: Global Nuclear Medicine Market By Endocrine Tumor, Market Forecast(2015-2027)(US $MN)
  • Table 25: Global Nuclear Medicine Market By Bone Metastasis, Market Forecast(2015-2027)(US $MN)
  • Table 26: Global Nuclear Medicine Market By Other Therapeutic Application, Market Forecast(2015-2027)(US $MN)
  • Table 27: Global Nuclear Medicine Market By Diagnostic Application, Market Forecast(2015-2027)(US $MN)
  • Table 28: Global Nuclear Medicine Market By Oncology, Market Forecast(2015-2027)(US $MN)
  • Table 29: Global Nuclear Medicine Market By Cardiology, Market Forecast(2015-2027)(US $MN)
  • Table 30: Global Nuclear Medicine Market By Neurology, Market Forecast(2015-2027)(US $MN)
  • Table 31: Global Nuclear Medicine Market By Other Diagnostic Application, Market Forecast(2015-2027)(US $MN)

NOTE: Tables for North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the World are represented in the same manner above.

目次

The Global Nuclear Medicine Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include increasing incidents of cancer and cardiac ailments, increasing SPECT and PET applications, growing public awareness for healthcare.

Based on the product, market is segregated into therapeutic products and diagnostic products. Therapeutic products are sub divided into brachytherapy, alpha emitters, beta emitters. Brachytherapy is sub classified into palladium - 103, iridium - 192, iodine - 125, cesium - 131 and other brachytherapy products. Alpha Emitters is sub segmented into RA - 223 and other alpha emitters. Beta Emitters is bifurcated into SM - 153, Y - 90, Lu - 117, Re - 186, I - 131 and other beta emitters. Diagnostic Products is sub divided into PET and SPECT. PET is sub classified into SR - 82/RB - 82, F -18 and other PET products. SPECT is sub segmented into TL - 201, I - 123, TC - 99m, GA - 67 and other SPECT products.

Depending on the application, market is divided into therapeutic application and diagnostic application. Therapeutic application is segmented into lymphoma, thyroid, endocrine tumor, bone metastasis and other therapeutic application. Diagnostic application is classified into oncology, cardiology, neurology and other diagnostic application.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific

Middle East

  • Saudi Arabia
  • UAE
  • Rest of Middle East

Latin America

  • Argentina
  • Brazil
  • Rest of Latin America

Rest of the World

  • South Africa
  • Others

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Table of Contents

1. Market Outline

  • 1.1. Research Methodology
    • 1.1.1. Research Approach & Sources
  • 1.2. Market Trends
  • 1.3. Regulatory Factors
  • 1.4. Product Analysis
  • 1.5. Application Analysis
  • 1.6. Strategic Benchmarking
  • 1.7. Opportunity Analysis

2. Executive Summary

3. Market Overview

  • 3.1. Current Trends
    • 3.1.1. Increasing Incidents of Cancer and Cardiac Ailments
    • 3.1.2. Increasing Spect Radiopharmaceuticals and Pet Radiopharmaceuticals Applications
    • 3.1.3. Growing Public Awareness for Healthcare
    • 3.1.4. Growth Opportunities/Investment Opportunities
  • 3.2. Drivers
  • 3.3. Constraints
  • 3.4. Industry Attractiveness
    • 3.4.1. Bargaining power of suppliers
    • 3.4.2. Bargaining power of buyers
    • 3.4.3. Threat of substitutes
    • 3.4.4. Threat of new entrants
    • 3.4.5. Competitive rivalry

4. Nuclear Medicine Market, By Product

  • 4.1. Therapeutic Products
    • DATA TABLE: Therapeutic Products Market Forecast to 2027(US$ MN)
    • 4.1.1. Brachytherapy
    • DATA TABLE: Brachytherapy Market Forecast to 2027(US$ MN)
      • 4.1.1.1. Palladium - 103
      • 4.1.1.2. Iridium - 192
      • 4.1.1.3. Iodine - 125
      • 4.1.1.4. Cesium - 131
      • 4.1.1.5. Other Brachytherapy Products
    • 4.1.2. Alpha Emitters
    • DATA TABLE: Alpha Emitters Market Forecast to 2027(US$ MN)
      • 4.1.2.1. RA - 223
      • 4.1.2.2. Other Alpha Emitters
    • 4.1.3. Beta Emitters
    • DATA TABLE: Beta Emitters Market Forecast to 2027(US$ MN)
      • 4.1.3.1. SM - 153
      • 4.1.3.2. Y - 90
      • 4.1.3.3. Lu - 117
      • 4.1.3.4. Re - 186
      • 4.1.3.5. I - 131
      • 4.1.3.6. Other Beta Emitters
  • 4.2. Diagnostic Products
    • DATA TABLE: Diagnostic Products Market Forecast to 2027(US$ MN)
    • 4.2.1. PET Radiopharmaceuticals
    • DATA TABLE: PET Radiopharmaceuticals Market Forecast to 2027(US$ MN)
      • 4.2.1.1. SR - 82/RB - 82
      • 4.2.1.2. F -18
      • 4.2.1.3. Other PET Products
    • 4.2.2. SPECT Radiopharmaceuticals
    • DATA TABLE: SPECT Radiopharmaceuticals Market Forecast to 2027(US$ MN)
      • 4.2.2.1. TL - 201
      • 4.2.2.2. I - 123
      • 4.2.2.3. TC - 99m
      • 4.2.2.4. GA - 67
      • 4.2.2.5. Other SPECT Products

5. Nuclear Medicine Market, By Procedures

  • 5.1. Central Nervous System
    • DATA TABLE: Central Nervous System Market Forecast to 2027(US$ MN)
  • 5.2. Gastrointestinal
    • DATA TABLE: Gastrointestinal Market Forecast to 2027(US$ MN)
  • 5.3. Pulmonary
    • DATA TABLE: Pulmonary Market Forecast to 2027(US$ MN)
  • 5.4. Therapeutic
    • DATA TABLE: Therapeutic Market Forecast to 2027(US$ MN)
  • 5.5. Cardiovascular
    • DATA TABLE: Cardiovascular Market Forecast to 2027(US$ MN)
  • 5.6. Endocrine
    • DATA TABLE: Endocrine Market Forecast to 2027(US$ MN)
  • 5.7. Genito-Urinary
    • DATA TABLE: Genito-Urinary Market Forecast to 2027(US$ MN)
  • 5.8. PET & PET-CT
    • DATA TABLE: PET & PET-CT Market Forecast to 2027(US$ MN)
  • 5.9. Skeletal
    • DATA TABLE: Skeletal Market Forecast to 2027(US$ MN)
  • 5.10. Other Procedures
    • DATA TABLE: Other Procedures Market Forecast to 2027(US$ MN)

6. Nuclear Medicine Market, By Application

  • 6.1. Therapeutic Application
    • DATA TABLE: Therapeutic Application Market Forecast to 2027(US$ MN)
    • 6.1.1. Lymphoma
    • DATA TABLE: Lymphoma Market Forecast to 2027(US$ MN)
    • 6.1.2. Thyroid
    • DATA TABLE: Thyroid Market Forecast to 2027(US$ MN)
    • 6.1.3. Endocrine Tumor
    • DATA TABLE: Endocrine Tumor Market Forecast to 2027(US$ MN)
    • 6.1.4. Bone Metastasis
    • DATA TABLE: Bone Metastasis Market Forecast to 2027(US$ MN)
    • 6.1.5. Other Therapeutic Application
    • DATA TABLE: Other Therapeutic Application Market Forecast to 2027(US$ MN)
  • 6.2. Diagnostic Application
    • DATA TABLE: Diagnostic Application
    • 6.2.1. Oncology
    • DATA TABLE: Oncology Market Forecast to 2027(US$ MN)
    • 6.2.2. Cardiology
    • DATA TABLE: Cardiology Market Forecast to 2027(US$ MN)
    • 6.2.3. Neurology
    • DATA TABLE: Neurology Market Forecast to 2027(US$ MN)
    • 6.2.4. Other Diagnostic Application
    • DATA TABLE: Other Diagnostic Application Market Forecast to 2027(US$ MN)

7. Nuclear Medicine Market, By Geography

  • 7.1. North America
    • DATA TABLE: North America Market Forecast by Countries to 2027(US$ MN)
    • 7.1.1. US
    • 7.1.2. Canada
    • 7.1.3. Mexico
  • 7.2. Europe
    • DATA TABLE: Europe Market Forecast by Countries to 2027(US$ MN)
    • 7.2.1. Germany
    • 7.2.2. U.K
    • 7.2.3. Italy
    • 7.2.4. France
    • 7.2.5. Spain
    • 7.2.6. Rest of Europe
  • 7.3. Asia Pacific
    • DATA TABLE: Asia Pacific Market Forecast by Countries to 2027(US$ MN)
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. New Zealand
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Middle East
    • DATA TABLE: Middle East Market Forecast by Countries to 2027(US$ MN)
    • 7.4.1. Saudi Arabia
    • 7.4.2. UAE
    • 7.4.3. Rest of Middle East
  • 7.5. Latin America
    • DATA TABLE: Latin America Market Forecast by Countries to 2027(US$ MN)
    • 7.5.1. Argentina
    • 7.5.2. Brazil
    • 7.5.3. Rest of Latin America
  • 7.6. Rest of the World(RoW)
    • DATA TABLE: RoW Market Forecast by Countries to 2027(US$ MN)
    • 7.6.1. South Africa
    • 7.6.2. Others

8. Key Player Activities

  • 8.1. Acquisitions & Mergers
  • 8.2. Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.3. Product Launch & Expansions
  • 8.4. Other Activities

9. Leading Companies

  • 9.1. GE Healthcare
  • 9.2. Siemens Healthcare
  • 9.3. NTP Radioisotopes
  • 9.4. Cardinal Health, Inc.
  • 9.5. Lantheus Holdings
  • 9.6. Triad Isotopes
  • 9.7. Fujifilm Holdings Corporation
  • 9.8. Sigma-Aldrich Corporation.
  • 9.9. Cambridge Isotope Laboratories, Inc.
  • 9.10. Nordion, Inc.
  • 9.11. IBA Group
  • 9.12. Eczacibasi-Monrol
  • 9.13. Bracco S.p.A.
  • 9.14. Medtronic
  • 9.15. Jubilant Pharma LLC
Back to Top